CoCrystal Pharma to Present at August 20th Virtual Investor Summit Microcap Event
CoCrystal Pharma (NASDAQ:COCP), a clinical-stage biotechnology company focused on developing novel antiviral therapeutics, is set to present at the virtual Investor Summit Microcap Forum on August 20, 2024.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
CoCrystal Pharma (NASDAQ:COCP), a clinical-stage biotechnology company focused on developing novel antiviral therapeutics, is set to present at the virtual Investor Summit Microcap Forum on August 20, 2024. The event, themed around 50 micro-cap companies with catalysts or strong market performance, offers a platform for CoCrystal's management to showcase their company overview at 9:00 a.m. ET.
The presentation will highlight CoCrystal's work in targeting the replication process of influenza viruses, coronaviruses, and noroviruses. Investors will have the opportunity to engage in live Q&A sessions and schedule one-on-one meetings with the management team throughout the day. This event provides a valuable opportunity for qualified investors to gain insights into CoCrystal's progress and potential in the antiviral therapeutics market.
Details
News Market Reaction – COCP
The recorded move for COCP in the trading session of this news was +0.59%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
NEW YORK, NY / ACCESSWIRE / August 15, 2024 / CoCrystal Pharma (NASDAQ:COCP), a clinical-stage biotechnology company discovering and developing novel antiviral therapeutics that target the replication process of influenza viruses, coronaviruses and noroviruses, announces that management will present a company overview at the virtual Investor Summit Microcap Forum being held Tuesday, August 20, 2024. Management will be available for 1-on-1 meetings throughout the day.
Qualified investors can register here to view the live presentation and to ask questions.
Event: Q3 Investor Summit
Date: August 20th, 2024
Presentation Time: 9:00 a.m. ET (6:00 a.m. PT)
Location: WEBCAST LINK
The theme is 50 micro-cap companies with a catalyst and/or strong performance in the current market.
Take a deep dive with the best Investors in MicroCap
Live Q & A
Complimentary to Qualified Investors. Please REGISTER HERE.
About Cocrystal Pharma
Cocrystal Pharma, Inc. is a clinical-stage biotechnology company discovering and developing novel antiviral therapeutics that target the replication process of influenza viruses, coronaviruses (including SARS-CoV-2), noroviruses and hepatitis C viruses. Cocrystal employs unique structure-based technologies and Nobel Prize-winning expertise to create first- and best-in-class antiviral drugs. For further information about Cocrystal, please visit www.cocrystalpharma.com.
About the Investor Summit
The Investor Summit is an exclusive, independent conference dedicated to connecting smallcap and microcap companies with qualified investors. Founded in 2015.
Contact:
Fred Rockwell
fred@investorsummitgroup.com
Investor Summit Group
SOURCE: CoCrystal Pharma
View the original press release on accesswire.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.